InvestorsHub Logo
Followers 8
Posts 329
Boards Moderated 0
Alias Born 01/12/2012

Re: markkind post# 4018

Friday, 02/24/2012 1:57:38 PM

Friday, February 24, 2012 1:57:38 PM

Post# of 30372
We are way past Phase I, Markkind..

I believe 2 Phase III's have been performed ( not 100% sure but almost certain )..

As far as Femprox being approved by default.. Do not think so..!
It will help.. I think..

Markkind.. By the way.. You probably still have in your mind Courtfool's endless posts on how Vitaros is the Same as Femprox..?
I asked Ed Cox this question .. Over a year ago.. And he said they were different ( that was all he would say )..

Now.. They both contain Alprostadil and NexAct.. They are the Same in that..!

The Difference I can see is that Apricus' Vitaros is approved ( at least in Canada ) in doses of 220 mcg and 330 mcg of Alprostadil..!

In the Clinical Trials ran for Femprox.. Especially the Phase III trial.. They acheived Statistical Significance and the BEST Results while applying Femprox at the Highest Dose.. Which happens to be 900 mcg..!

That is almost 3 times the highest dose of Vitaros..!

So, just by this I would say that the Approval of Femprox would not be by Default..!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News